Citation Impact
Citing Papers
Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O 2 -Regulated Prolyl Hydroxylation
2001 StandoutScienceNobel
Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney
2006 StandoutNobel
The structure of aconitase
1989
Chicken ceruloplasmin. Evidence in support of a trinuclear cluster involving type 2 and 3 copper centers.
1988
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies
2010 Standout
Age-related changes in human ceruloplasmin. Evidence for oxidative modifications
1993
The stoichiometry of the paramagnetic copper and the oxidation-reduction potentials of type I copper in human ceruloplasmin
1973
Demonstration by NMR of folding domains in lysozyme
1991 StandoutNatureNobel
The blue oxidases, ascorbate oxidase, laccase and ceruloplasmin Modelling and structural relationships
1990 Nobel
Frequent ICD Shocks due to Double Sensing in Patients with Bi-Ventricular Implantable Cardioverter Defibrillators
2003
Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?
2016 Standout
Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation
2004
Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study
1995
Structure of azurin from Alcaligenes denitrificans refinement at 1·8 Å resolution and comparison of the two crystallographically independent molecules
1988
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
2003
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008
Factors leading to progression of valvular aortic stenosis
1999
The effect of albumin, ceruloplasmin, and other serum constitutents on Fe(II) oxidation
1982
Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass Grafts
1998
Purification and partial characterization of goose ceruloplasmin
1988
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
1991 Nobel
Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up
1999
T lymphocyte infiltration in non-rheumatic aortic stenosis: a comparative descriptive study between tricuspid and bicuspid aortic valves
2002
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Association of Aortic-Valve Sclerosis with Cardiovascular Mortality and Morbidity in the Elderly
1999
Nucleotide Sequence of a cDNA Clone Encoding an Acidic Laccase from Sycamore Maple (Acer pseudoplatanus L.)
1995
The 50-Year History, Controversy, and Clinical Implications of Left Ventricular Outflow Tract Obstruction in Hypertrophic Cardiomyopathy
2009
Biventricular mechanical asynchrony predicts hemodynamic effect of uni- and biventricular pacing
2003
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment
2004
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Adhesion molecules in nonrheumatic aortic valve disease: endothelial expression, serum levels and effects of valve replacement
2000
An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor
1996 StandoutNobel
Usefulness of B-type Natriuretic Peptide Levels in Predicting Hemodynamic and Clinical Decompensation
2009
Cobalt and desferrioxamine reveal crucial members of the oxygen sensing pathway in HepG2 cells
1997
Update on recent clinical trials in congestive heart failure
2000
Optimal Pharmacologic and Non-pharmacologic Management of Cardiac Transplant Candidates: Approaches to Be Considered Prior to Transplant Evaluation: International Society for Heart and Lung Transplantation Guidelines for the Care of Cardiac Transplant Candidates—2006
2006
The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study
2004
Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial
2009
How should we manage symptomatic aortic stenosis in the patient who is 80 or older?
1995
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM)–Added trial
2006
A randomized comparison ofatrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome
2003
Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study
2001
Systolic anterior motion begins at low left ventricular outflow tract velocity in obstructive hypertrophic cardiomyopathy
2000
Markers of Dysglycaemia and Risk of Coronary Heart Disease in People without Diabetes: Reykjavik Prospective Study and Systematic Review
2010
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices—Summary Article
2002
Dual Chamber Pacing for Patients With Hypertrophic Obstructive Cardiomyopathy: A Clinical Perspective in 2000
2000
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
1998 StandoutNobel
Cardiac Resynchronization in Chronic Heart Failure
2002 Standout
Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure
2002
Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
1999
Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome
1999
Pacemaker implantation and quality of life in the Mode Selection Trial (MOST)
2006
Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
1997 StandoutNatureNobel
HYPERTROPHIC AND RESTRICTIVE CARDIOMYOPATHIES THE ELDERLY
1999
Task Force on Sudden Cardiac Death of the European Society of Cardiology
2001
Efficacy and safety ofdigoxin alone and in combination with low-dosediltiazem orbetaxolol to control ventricular rate in chronic atrial fibrillation
1995
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary
2008
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2016
Do Current Dual Chamber Cardioverter Defibrillators Have Advantages Over Conventional Single Chamber Cardioverter Defibrillators in Reducing Inappropriate Therapies? A Randomized, Prospective Study
2001
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
2009
Characterization of a laccase gene from the white-rot fungus Trametes versicolor and structural features of basidiomycete laccases
1995
Functional abnormalities in patients with permanent right ventricular pacing
2002
Structure of the first C2 domain of synaptotagmin I: A novel Ca2+/phospholipid-binding fold
1995 StandoutNobel
Lesser Response to Angiotensin-Converting–Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction
2001
Hypertrophic Cardiomyopathy
2002 Standout
ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices: Summary Article
2002
Prospective Randomized Study of Mode Switching in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2004
A Randomized Trial of Intensive Lipid-Lowering Therapy in Calcific Aortic Stenosis
2005 Standout
Acute and long-term results after transcoronary ablation of septal hypertrophy (TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy
1999
Nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy: one-year follow-up
2000
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2004
Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study
2002
Applications of reversible covalent chemistry in analytical sample preparation
2012
The pathophysiology of acute heart failure—Is it all about fluid accumulation?
2007
Altered Cardiac Histology Following Apical Right Ventricular Pacing in Patients with Congenital Atrioventricular Block
1999
Effects of Physiologic Pacing versus Ventricular Pacing on the Risk of Stroke and Death Due to Cardiovascular Causes
2000
Dual-Chamber Pacing for Cardiomyopathies: A 1996 Clinical Perspective
1996
Unusual stability properties of a reptilian ceruloplasmin
1990
Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing
1998
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis
2002
Enhanced Detection Criteria in Implantable Cardioverter-Defibrillators to Avoid Inappropriate Therapy
1996
Clinical Factors Associated With Calcific Aortic Valve Disease
1997 Standout
Pharmacological rate control of atrial fibrillation
2004
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
1994 StandoutNatureNobel
Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome
1997
X-ray crystal structure of the two site-specific mutants His35Gln and His35Leu of azurin from Pseudomonas aeruginosa
1991 Nobel
Septal myotomy–myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
2002
To operate or not on elderly patients with aortic stenosis: the decision and its consequences
1999
Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens
1999
Clinical Course of Hypertrophic Cardiomyopathy in a Regional United States Cohort
1999
Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation
2004
Diabetes mellitus and congestive heart failure
1999
Human copper-containing superoxide dismutase of high molecular weight.
1982
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
Hidden Markov models of biological primary sequence information.
1994 StandoutNobel
Role of the alpha-amino group of protein in ubiquitin-mediated protein breakdown.
1984 StandoutNobel
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2011
A crystallographic model for azurin at 3 Å resolution
1978
Structural patterns in globular proteins
1976 StandoutNatureNobel
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
2005 Standout
Dual Chamber Pacing for Patients With Hypertrophic Obstructive Cardiomyopathy: A Clinical Perspective in 2000
2000
The amino acid sequence of stellacyanin from the lacquer tree
1977
The amino acid sequence of rabbit skeletal muscle troponin C: Gene replication and homology with calcium ‐binding proteins from carp and hake muscle
1973
Generation of parvalbumin-like proteins from troponin
1974 StandoutNobel
Degradation of Proteins with Acetylated Amino Termini by the Ubiquitin System
1989 StandoutScienceNobel
Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis.
1985 StandoutNobel
Structure of the metal clusters in rabbit liver metallothionein
1980
Effect of pH on Electron‐Paramagnetic‐Resonance Spectra of Ceruloplasmin
1973
Gene Triplication deduced from the Tertiary Structure of a Muscle Calcium Binding Protein
1972
Preferential binding of copper to the beta domain of metallothionein.
1984
Multicopper Oxidases and Oxygenases
1996 Standout
Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction
2003
Domain nature of metallothionein.
1982
Altering the Genome by Homologous Recombination
1989 StandoutScienceNobel
Purification and partial characterization of ceruloplasmin from chicken serum
1985
Laccase and the Deposition of Lignin in Vascular Plants
1994
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Phase Determination by Multiple-Wavelength X-Ray Diffraction: Crystal Structure of a Basic "Blue" Copper Protein from Cucumbers
1988 Science
Novel cysteine-rich motif and homeodomain in the product of the Caenorhabditis elegans cell lineage gene lin-II
1990 StandoutNatureNobel
Evaluating Quality of Care for Patients With Heart Failure
2000
The EuroHeart Failure Survey programme—a survey on the quality of care among patients with heart failure in Europe Part 2: treatment
2003
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
1976 Standout
Molar absorptivity and A1cm1% values for proteins at selected wavelengths of the ultraviolet and visible regions. VIII
1973
Long Range Electron Transfer in Blue Copper Proteins
1991
Structural and Functional Aspects of Metal Sites in Biology
1996 Standout
Carp Muscle Calcium-binding Protein
1973 Standout
Structure And Evolution Of Calcium-Modulated Protein
1980
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
The protein products of the myc and myb oncogenes and adenovirus E1a are structurally related
1983 StandoutNatureNobel
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule.
1984
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009
Domainal evolution of a prokaryotic DNA repair protein and its relationship to active-transport proteins
1986 StandoutNatureNobel
Experimental studies of protein folding and unfolding
1979
2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2016
Anion-binding and the state of copper in caeruloplasmin
1973
A novel ras-related gene family
1985 StandoutNobel
Percutaneous Transluminal Septal Myocardial Ablation in Hypertrophic Obstructive Cardiomyopathy
1998
Evolving Indications for Permanent Pacemakers
2001
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Apolipoproteins B, (a), and E Accumulate in the Morphologically Early Lesion of ‘Degenerative’ Valvular Aortic Stenosis
1996 Standout
Low molecular weight proteins of pike (Esox lucius) white muscles—II. Chemical and physical properties
1973
Purification and properties of bovine caeruloplasmin
1981
Pitfalls in Clinical Recognition and a Novel Operative Approach for Hypertrophic Cardiomyopathy With Severe Outflow Obstruction Due to Anomalous Papillary Muscle
1998
Prospective Study of Asymptomatic Valvular Aortic Stenosis
1997
Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma
2002
Structural Features of Azurin at 2.7 Å Resolution
1981
Evidence that approximately eighty per cent of the soluble proteins from Ehrlich ascites cells are Nalpha-acetylated.
1976
Isolation and Characterization of Parvalbumins from the Skeletal Muscle of Higher Vertebrates
1974 StandoutNobel
Isolation and characterization of the main parvalbumins from Raja clavata and Raja montagui white muscles
1972
Homology of myosin light chains, troponin-C and parvalbumins deduced from comparison of their amino acid sequences
1974
A Phosphate-Acceptor Protein Related to Parvalbumins in Dogfish Skeletal Muscle
1974 StandoutNobel
ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2008 Standout
Ischemic Mitral Regurgitation on the Threshold of a Solution
2005
Binding and uptake of copper from ceruloplasmin
1986
Aortocoronary Saphenous Vein Graft Disease
1998 Standout
Structure of activated aconitase: formation of the [4Fe-4S] cluster in the crystal.
1989
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Ascorbate Oxidase from Cucurbita pepo medullosa
1979
Protein Control of Redox Potentials of Iron−Sulfur Proteins
1996 StandoutNobel
Electrocardiographic changes after alcohol septal ablation in hypertrophic obstructive cardiomyopathy
1998
Cardiac βARK1 inhibition prolongs survival and augments β blocker therapy in a mouse model of severe heart failure
2001 StandoutNobel
Coordination environment and fluoride binding of type 2 copper in the blue copper oxidase ceruloplasmin.
1978
Amino-acid sequence of parvalbumin from rabbit skeletal muscle.
1975 StandoutNobel
Carp Muscle Calcium-binding Protein
1973
Nucleotide sequence of Escherichia coli pabA and its evolutionary relationship to trp (G) D
1983 StandoutNobel
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
X-ray crystal structure analysis of plastocyanin at 2.7 Å resolution
1978 Nature
Crystal structure of the membrane-exposed domain from a respiratory quinol oxidase complex with an engineered dinuclear copper center.
1995
The amino acid sequence of the pike (Esox lucius) parvalbumin III
1973
ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation
2006
Heart Failure and Echocardiographic Changes During Long-term Follow-up of Patients With Sick Sinus Syndrome Randomized to Single-Chamber Atrial or Ventricular Pacing
1998
The binding of calcium to muscular parvalbumins
1972
Gadolinium Cardiovascular Magnetic Resonance Predicts Reversible Myocardial Dysfunction and Remodeling in Patients With Heart Failure Undergoing β-Blocker Therapy
2003
The Primary Structure of the Major Parvalbumin from Hake Muscle
1973
Structure of a Calcium-Binding Carp Myogen
1972
Assessment of Permanent Dual-Chamber Pacing as a Treatment for Drug-Refractory Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
1999
Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients
2000
Conformational studies on muscular parvalbumins
1974
Potential Metal-Binding Domains in Nucleic Acid Binding Proteins
1986 Science
Similar Amino Acid Sequences: Chance or Common Ancestry?
1981 Science
Presence of Oxidized Low Density Lipoprotein in Nonrheumatic Stenotic Aortic Valves
1999
Troponins C from reptile and fish muscles and their relation to muscular parvalbumins
1974
Diabetes Patients Requiring Glucose-Lowering Therapy and Nondiabetics With a Prior Myocardial Infarction Carry the Same Cardiovascular Risk
2008
Translocation of C. elegans CED-4 to Nuclear Membranes During Programmed Cell Death
2000 StandoutScienceNobel
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina11This document was approved by the American College of Cardiology Board of Trustees in March 1999, the American Heart Association Science Advisory and Coordinating Committee in March 1999, and the American College of Physicians-American Society of Internal Medicine Board of Regents in February 1999.When citing this document, please use the following citation format: Gibbons RJ, Chatterjee K, Daley J, Douglas JS, Fihn SD, Gardin JM, Grunwald MA, Levy D, Lytle BW, O’Rourke RA, Schafer WP, Williams SV. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 1999;33:2092–197.This document is available on the World Wide Web sites of the American College of Cardiology (www.acc.org) and the American Heart Association (www.americanheart.org). Reprints of this document are available by calling 1-800-253-4636 or writing the American College of Cardiology, Educational Services, at 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint number 71-0166. To obtain a reprint of the Executive Summary and Recommendations published in the June 1, 1999 issue of Circulation, ask for reprint number 71-0167. To purchase bulk reprints (specify version and reprint number): Up to 999 copies call 1-800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org
1999
Complete cDNA sequence of human preceruloplasmin.
1986
Prevention of Ventricular Desynchronization by Permanent Para-Hisian Pacing After Atrioventricular Node Ablation in Chronic Atrial Fibrillation
2006
2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities
2012
Sheep ceruloplasmin: isolation and characterization
1983
Management of Symptoms in Hypertrophic Cardiomyopathy
2008
Chemical Glycoproteomics
2016 StandoutNobel
Development of Congestive Heart Failure in Type 2 Diabetic Patients With Microalbuminuria or Proteinuria
2003
The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death
1992 StandoutNobel
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011
A gelsolin-like Ca2+-dependent actin-binding domain in villin
1985 StandoutNatureNobel
Works of Lars Rydén being referenced
Acute cobalt exposure and oxygen radical scavengers in the rat myocardium
1993
Quality-of-Life in Patients Treated with Atrioventricular Synchronous Pacing Compared to Rate Modulated Ventricular Pacing: A Long-Term, Double-Blind, Crossover Study
1992
Ongoing right ventricular hemodynamics in heart failure
2003
Ventricular control and exercise performance in chronic atrial fibrillation: Effects of diltiazem verapamil
1990
A Double‐Blind Study of Submaximal Exercise Tolerance and Variation in Paced Rate in Atrial Synchronous Compared to Activity Sensor Modulated Ventricular Pacing
1992
Holter Documented Sudden Death in a Patient with an Implanted Defibrillator
1992
Effects of insulin treatment on cause-specific one-year mortality and morbidity in diabetic patients with acute myocardial infarction
1996
Accumulation of T lymphocytes and expression of interleukin-2 receptors in nonrheumatic stenotic aortic valves
1994
Evidence for proteolytic fragments in commercial samples of human ceruloplasmin
1971
Aortic valve replacement in octogenarians with aortic stenosis: A case-control study
1992
Monitoring of pulmonary arterial diastolic pressure through a right ventricular pressure transducer
1995
Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy
1996
The Effect of Ventricular Activation Sequence on Cardiac Performance During Pacing
1996
Efficacy and safety of high-dose lisinopril in chronic heart failure patients at high cardiovascular risk, including those with diabetes mellitus. Results from the ATLAS trial
2000
Toleration of High Doses of Angiotensin-Converting Enzyme Inhibitors in Patients With Chronic Heart Failure
2001
Noninvasive techniques in the evaluation of the arrhythmogenic effects
1988
Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study
1997
The Benefits of Early Combination Treatment of Carvedilol and an ACE-Inhibitor in Mild Heart Failure and Left Ventricular Systolic Dysfunction. The Carvedilol and ACE-Inhibitor Remodelling Mild Heart Failure Evaluation Trial (CARMEN)
2004
Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest
1997
Evolution of protein complexity: The blue copper-containing oxidases and related proteins
1993
Reduction of hospital days by biventricular pacing
2000
Differential effects of xamoterol and verapamil on ventricular rate regulation in patients with chronic atrial fibrillation
1992
Comparison of metoprolol and verapamil in the treatment of angina pectoris
1982
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
1999 Standout
Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase)
1976
Guidelines on Diabetes, Pre-Diabetes, and Cardiovascular Diseases: Executive Summary
2007
Model of the active site in the blue oxidases based on the ceruloplasmin-plastocyanin homology.
1982
Preparation and properties of the major copper-binding component in human fetal liver. Its identification as metallothionein.
1978
Molecular weight of beef heart aconitase and stoichiometry of the components of its iron-sulfur cluster.
1984
Covalent chromatography as a means of isolating thiol peptides from large proteins
1981
Rimonabant as an adjunct therapy in overweight/obese patients with type 2 diabetes: reply
2007
Homology relationships among the small blue proteins
1976 Nature
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death
2000
The Primary Structure of the Major Parvalbumin from Hake Muscle. Isolation and General Properties of the Protein
1971
On the evolution of blue proteins
1979
Human ceruloplasmin as a polymorphic glycoprotein. Tryptic glycopeptides from two forms of the protein.
1971
The amino acid sequence of the major parvalbumin from hake muscle
1971
Causes of more frequent deletions than insertions in mutations and protein evolution
1981 Nature
A Model Of The Three‐Dimensional Structure Of Snake Venom Neurotoxins Based On Chemical Evidence
1973
Haemostatic Factors and Inhibitors and Coronary Artery Bypass Grafting: Preoperative Alterations and Relations to Graft Occlusion
1994
Single‐Chain Structure of Human Ceruloplasmin
1972
Comparison of Polypeptide‐Chain Structure of Four Mammalian Ceruloplasmins by Gel Filtration in Guanidine Hydrochloride Solutions
1972
The Primary Structure of the Major Parvalbumin from Hake Muscle
1973